menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Breast Biopsy Device Market
Breast Biopsy Device Market

Breast Biopsy Device Market

Published date: Nov 2021 • Formats:
Request Sample Buy Now
  • Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Breast Biopsy Device Market

Global Breast Biopsy Device Market By Test Type (Open Surgical Biopsy, Needle Breast Biopsy), By Product (Biopsy Tables, Biopsy Needles, and Others), By Guidance Type (Magnetic Resonance Guided Biopsies, Mammography-Guided Stereotactic, Ultrasound-Guided), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • account_circleAbout Me

    Quick Navigation

    • 1 Breast Biopsy Device Market Overview:
    • 2 Global Breast Biopsy Device Market
      • 2.1 Test Type Analysis
      • 2.2 Product Analysis
      • 2.3 Guidance Type Analysis
    • 3 Key Market Segments
      • 3.1 Test Type
      • 3.2 Product
      • 3.3 Guidance Type
    • 4 Market Dynamics
    • 5 Regional Analysis
    • 6 Key Regions and Countries covered іn thе rероrt:
    • 7 Market Share Analysis
    • 8 Key Market Players

    Breast Biopsy Device Market Overview:

    The market size for breast biopsy devices was USD 601.67 million in 2021 at a CAGR of 8.3%.

    Global Breast Biopsy Device Market

    Test Type Analysis

    This industry is divided by type into open and needle surgical biopsies. The former can be further classified into fine-needle aspiration, core needle biopsy, or vacuum-assisted central biopsy.

    In 2021, the market share for fine-needle extraction is expected to be the highest due to increased demand for minimally invasive procedures.

    Vacuum-assisted Core Biopsy is expected to grow at an impressive CAGR value over the forecast period. This technique involves making a small incision through the skin, inserting the needle, and then taking samples using a vacuum-powered device.

    breast biospy device market

    Product Analysis

    The industry’s most important products include needles and tables, localization cables, and guidance systems, among others. A large portion of the market was dominated by needles in 2021. This is due to its broad application in the needle breast market. Most of the advancements and enhancements can be seen in the products category.

    Stryker Precise Core’s needle allows for sample acquisition with greater precision, and less tissue damage. The guidance system product segment is also expected to experience a significant growth rate over the forecast period.

    Guidance Type Analysis

    Guidance systems are needed to locate abnormalities in the breasts during biopsy procedures. The available guiding systems for biopsy include mammography-guided stereotactic (Ultrasound-guided), and magnetic resonance-guided biopsies. They are used to detect and locate abnormal cell growths.

    The sector’s largest share is made up of the mammography-guided segment. However, false positives are possible due to the dense breast tissue image. The ultrasound-guided procedure produces more accurate results. It is expected to see the highest rate of growth during the study period.

    Key Market Segments

    Test Type

    • Open Surgical Biopsy
    • Needle Breast Biopsy

    Product

    • Biopsy Tables
    • Biopsy Needles
    • Guidance Systems
    • Localization Wires

    Guidance Type

    • Magnetic Resonance Guided Biopsies
    • Mammography-Guided Stereotactic
    • Ultrasound-Guided

    Market Dynamics

    It involves the removal of liquid from suspicious tissue. It requires the use of a guiding device, which helps to find a lump or abnormality within the breast region.

    Mammography, ultrasound, and magnetic resonance imaging are all used as guiding systems for the detection of breast cancer. Because of the growing demand for non-radiation biopsies, and the increased demand for minimally invasive procedures. The fastest segment growth is expected to be in the ultrasound segment.

    The market is expected to grow due to the increase in breast cancers and the rise in awareness programs.

    In addition, product enhancements will continue to be introduced in the market. These products are expected to have a positive effect on the industry over the forecast period. The Goal of C.R. Bard Truguide is disposable for the collection of tissue samples, coaxial biopsy needles with extremely thin sides offer exceptional efficiency and precision.

    However, there are risks that the procedure can pose to the Breast Biopsy Device market. The degree of risk is determined by the extent of the procedure. Although surgical core procedures can be more precise and effective, there are still major risks.

    Additionally, around 60% to 80% of biopsies are benign. It is important that women seek second opinions before considering any surgical procedure. This could negatively impact market growth.

    Regional Analysis

    The report covers North America as well as Europe, Asia Pacific, South America, and MEA. According to the market growth rate, Asia Pacific Breast Biopsy Device Market should experience the greatest growth. This growth can be attributed to the rising incidence of breast cancer among women.

    North America holds the largest share of the industry’s revenue in 2021. North America is the largest market, with a share of 48%. This is due in large part to the increased awareness generated through cancer screening programs, and other supportive government initiatives.

    breast biopsy market value regional share

    Key Regions and Countries covered іn thе rероrt:

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Russia
      • Spain
      • Rest of Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • MEA
      • GCC
      • South Africa
      • Israel
      • Rest of MEA

    Market Share Analysis

    Becton, C.R Bard Inc. Dickinson and Company, Devicor Medicals Products Inc., and Hologic Inc., are just a few of the major players in the Breast Biopsy Equipment Market. These companies are heavily involved in the development and implementation of strategic initiatives like joint ventures with FDA approvals, mergers, acquisitions, and mergers in order to retain their industry position.

    Hologic Inc. announced that in April 2016, the FDA approved the commercially available AffirmProne biopsy system. The new product includes 2D/3D imaging and guided systems.

    biopsy device market company share analysis

    Key Market Players

    • Becton
    • C.R Bard Inc.
    • Dickinson and Company
    • Devicor Medicals Products Inc.
    • Hologic Inc.
    • Other Key Players

    For the Breast Biopsy Devices Market research study, the following years have been considered to estimate the market size:

    Attribute Report Details

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Frequently Asked Questions (FAQ)

    Q: What is the size of the Breast Biopsy Device market in 2021?

    A: The Breast Biopsy Device market size was US$ 601.67 million in 2021.

    Q: What is the projected CAGR at which the Breast Biopsy Device market is expected to grow at?

    A: The Breast Biopsy Device market is expected to grow at a CAGR of 8.3% (2023-2032).

    Q: List the segments encompassed in this report on the Breast Biopsy Device market?

    A: Market.US has segmented the Breast Biopsy Device market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Test Type, market has been segmented into Open Surgical Biopsy, Needle Breast Biopsy. By Product, the market has been further divided into Biopsy Tables, Biopsy Needles, Guidance Systems, Localization Wires. By Guidance Type, the market has been further divided into Magnetic Resonance Guided Biopsies, Mammography-Guided Stereotactic, Ultrasound-Guided.

    Q: List the key industry players of the Breast Biopsy Device market?

    A: Becton, C.R Bard Inc., Dickinson and Company, Devicor Medicals Products Inc., Hologic Inc., and Other Key Players engaged in the Breast Biopsy Device market.

    Q: Which region is more appealing for vendors employed in the Breast Biopsy Device market?

    A: North America is accounted for the highest revenue share of 48%. Therefore, the Breast Biopsy Device industry in North America is expected to garner significant business opportunities over the forecast period.

    Q: Name the key areas of business for Breast Biopsy Device?

    A: The US, Canada, Mexico, UK, and France are key areas of operation for Breast Biopsy Device Market.

    Q: Which segment accounts for the greatest market share in the Breast Biopsy Device industry?

    A: With respect to the Breast Biopsy Device industry, vendors can expect to leverage greater prospective business opportunities through the needles segment, as this area of interest accounts for the largest market share.

    Breast Biopsy Device Market
    Breast Biopsy Device Market
    Published date: Nov 2021 • Formats:
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
  • ondemand_videoVideos
    • Becton, Dickinson and Company Profile
    • C.R Bard Inc.
    • Dickinson and Company
    • Devicor Medicals Products Inc.
    • Hologic Inc.
    • Other Key Players
  • settingsSettings

Our Clients

  • Our Clients

Inquiry Before Buying


Breast Biopsy Device Market
  • 18543
  • Nov 2021
    • ★★★★★
      ★★★★★
    • (36)
  • US $5,999
    US $4,499
  • US $7,999
    US $4,999
  • US $9,999
    US $5,499
Buy Now
✖

Request a Sample Report

We'll get back to you as quickly as possible

Single User
$5,999
$4,499
USD / per unit
save 25%
Multi User
$7,999
$4,999
USD / per unit
save 38%
Corporate User
$9,999
$5,499
USD / per unit
save 45%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

Secured Payment Options

Secured Payment Options

© 2023 Market.Us. All Rights Reserved.